1
Home
Companies

bioAffinity Technologies

#10288

Rank

$9.45M

Marketcap

US United States

Country

bioAffinity Technologies
Leadership team

Ms. Maria Zannes J.D. (Founder, Pres, CEO & Director)

Dr. Vivienne I. Rebel M.D., Ph.D. (Exec. VP and Chief Medical & Science Officer)

Mr. Michael Edwards CPA, M.B.A. (Chief Financial Officer)

Products/ Services
Biotechnology, Health Care, Therapeutics
Headquarters
San Antonio, Texas, United States
Established
2014
Company Registration
SEC CIK number: 0001712762
Traded as
BIAF
Social Media
URL
https://www.bioaffinitytech.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
History

BioAffinity Technologies was founded in 2000. Our founding team integrated biotechnology and pharmaceutical development technologies combined with novel microfluidic platforms, advanced drug delivery concepts, and smart polymer materials to develop new opportunities in personalized medicine and oral drug delivery.

Mission
Establish the highest level of trust with our clients, partners, and our patients. Our success is measured by developing breakthrough products and therapeutics while providing superior customer service.
Vision
We strive to be the world’s leading biotechnology company in oncology and other healthcare spaces, by revolutionizing how cancer and other diseases are treated through innovative treatments, technologies and products.
Key Team

Mr. Xavier T. Reveles M.S. (VP of Operations)

Mr. Timothy P. Zannes J.D. (Exec. VP, Sec. & Gen. Counsel)

Dr. William Bauta Ph.D. (Sr. VP of Therapeutics)

Recognition and Awards
BioAffinity Technologies has won numerous prestigious awards, including the National Institutes of Health Innovator’s Award, the Technology and Research Team Award for Innovation in Microfluidic Drug Delivery Technologies from the California Technology Institutes, and the Science and Technology Award from the World Oncology Forum.
References

https://in.investing.com/equities/bioaffinity-technologies

https://finance.yahoo.com/quote/BIAF/profile?p=BIAF

https://www.crunchbase.com/organization/bioaffinity-technologies

https://companiesmarketcap.com/

https://www.bioaffinitytech.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

bioAffinity Technologies
Leadership team

Ms. Maria Zannes J.D. (Founder, Pres, CEO & Director)

Dr. Vivienne I. Rebel M.D., Ph.D. (Exec. VP and Chief Medical & Science Officer)

Mr. Michael Edwards CPA, M.B.A. (Chief Financial Officer)

Products/ Services
Biotechnology, Health Care, Therapeutics
Headquarters
San Antonio, Texas, United States
Established
2014
Company Registration
SEC CIK number: 0001712762
Traded as
BIAF
Social Media
URL
https://www.bioaffinitytech.com